Sign Up Today and Learn More About Nervonik Stock
Invest in or calculate the value of your shares in Nervonik or other pre-IPO companies through EquityZen's platform.
Nervonik Stock
Nervonik is a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system.
About Nervonik Stock
Founded
2020
Headquarters
Los Angeles, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Nervonik Press Mentions
Stay in the know about the latest news on Nervonik
Chutes & Ladders: Ad trackers still on healthcare websites after lawsuits, FTC; the US Navy adds WHOOPs it up and expands Talkspace; HealthVerity to buy Symphony Health; Nervonik’s $52.5M Series B
telecareaware • May 07, 2026
The Weekly Notable Startup Funding Report: 5/4/26
alleywatch • May 06, 2026
Nervonik raises $52.5M to enhance peripheral nerve stimulation system
mobihealthnews • Apr 30, 2026
Nervonik closes $52.5m Series B funding to advance PNS system
medicaldevice-network • Apr 30, 2026
Nervonik raises $52.5M to advance PNS system
bioworld • Apr 30, 2026
Nervonik Management
Leadership team at Nervonik
Chief Operating Officer
Timothy Corvi
Founder and Board Member
Aydin Babakhani
Join now and verify your accreditation status to gain access to:
- Nervonik Current Valuation
- Nervonik Stock Price
- Nervonik Management
- Available deals in Nervonik and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Nervonik Cap Table and Funding History by Share Class and Liquidity Preferences
- Nervonik Revenue and Financials
- Nervonik Highlights
- Nervonik Business Model
- Nervonik Risk Factors
- Nervonik Research Report from SACRA Research
Trading Nervonik Stock
How to invest in Nervonik stock?
Accredited investors can buy pre-IPO stock in companies like Nervonik through EquityZen funds. These investments are made available by existing Nervonik shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Nervonik stock?
Shareholders can sell their Nervonik stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."